BSX
Boston Scientific Corporation
NYSE · USHealthcareMedical - Devices
$43.77-0.59%
Price as of Jul 20, 2026
BSX capital
Boston Scientific Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.43x
- Net debt / equity
- 0.37x
- Debt / assets
- 0.25x
- Debt / EBITDA
- 1.95x
- Net debt / EBITDA
- 1.68x
Liquidity & coverage
- Current ratio
- 1.90x
- Quick ratio
- 1.22x
- Cash ratio
- 0.33x
- Interest coverage
- 11.62x
- EBITDA / interest
- 15.85x
- Working capital
- $4.1B
Cash & dividend
- FCF / debt
- 0.31x
- Cash flow / debt
- 0.39x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.